Back to Results
First PageMeta Content
Lactams / Prodrugs / Schering-Plough / Temozolomide / Fax / Melanoma / Technology / Office equipment / Amides


REPRINT FROM APRIL 27, 2015 CLINICAL NEWS CLINICAL STATUS Provectus Biopharmaceuticals Inc. (NYSE-M:PVCT), Knoxville, Tenn.
Add to Reading List

Document Date: 2015-05-04 14:21:06

Open Document

File Size: 125,57 KB

Share Result on Facebook

City

WASHINGTON / DC / CARLOS / CHICAGO / Knoxville / /

Company

Getty Images / Provectus Biopharmaceuticals Inc. / BioCentury Publications Inc. / /

Country

United Kingdom / United States / /

/

Event

FDA Phase / /

/

MedicalCondition

Cancer / cutaneous melanoma / /

Organization

Because Real Intelligence / /

/

Position

weeks vs. investigator / /

Product

dacarbazine / PV-10 / /

ProvinceOrState

Tennessee / /

Technology

SAN / /

URL

www.biocentury.com / /

SocialTag